Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Hypoxia among patients on the liver-transplant waiting list.

Nacif LS, Andraus W, Sartori K, Benites CM, Santos VR, Rocha-Filho JA, D'Albuquerque LC.

Arq Bras Cir Dig. 2014 Jan-Mar;27(1):56-8.

2.

Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.

Ferraz-Neto BH, Hidalgo R, Thomé T, Melo VA Jr, Lobue A, Zurstrassen MP, Moraes JM Jr, Meira-Filho SP, Rezende MB, Fonseca LE, Pandullo FL, Soeiro FS, Afonso RC.

Transplant Proc. 2007 Oct;39(8):2511-3.

PMID:
17954160
3.

Case report of unchanged tacrolimus clearance in a hypoxemic pediatric liver transplant recipient with hepatopulmonary syndrome.

Sugimoto K, Ohmori M, Fujimura A, Sakamoto K, Hishikawa S, Mizuta K, Kita Y, Uno T, Kawarasaki H.

Transpl Int. 2004 Nov;17(10):643-6. Epub 2004 Oct 9.

4.

Cirrhosis and hepatopulmonary syndrome.

Tumgor G.

World J Gastroenterol. 2014 Mar 14;20(10):2586-94. doi: 10.3748/wjg.v20.i10.2586. Review.

5.

Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database.

Goldberg DS, Krok K, Batra S, Trotter JF, Kawut SM, Fallon MB.

Gastroenterology. 2014 May;146(5):1256-65.e1. doi: 10.1053/j.gastro.2014.01.005. Epub 2014 Jan 8.

6.

Childhood cirrhosis, hepatopulmonary syndrome and liver transplantation.

Tumgor G, Arikan C, Yuksekkaya HA, Cakir M, Levent E, Yagci RV, Kilic M, Aydogdu S.

Pediatr Transplant. 2008 May;12(3):353-7. doi: 10.1111/j.1399-3046.2007.00807.x.

PMID:
18435611
7.

Prevalence and severity of hepatopulmonary syndrome and its influence on survival in cirrhotic patients evaluated for liver transplantation.

Pascasio JM, Grilo I, López-Pardo FJ, Ortega-Ruiz F, Tirado JL, Sousa JM, Rodriguez-Puras MJ, Ferrer MT, Sayago M, Gómez-Bravo MA, Grilo A.

Am J Transplant. 2014 Jun;14(6):1391-9. doi: 10.1111/ajt.12713. Epub 2014 Apr 14.

8.

Successful treatment of severe hepatopulmonary syndrome with a sequential use of TIPS placement and liver transplantation.

Benítez C, Arrese M, Jorquera J, Godoy I, Contreras A, Loyola S, Domínguez P, Jarufe N, Martínez J, Pérez-Ayuso RM.

Ann Hepatol. 2009 Jan-Mar;8(1):71-4.

PMID:
19221539
9.

[Gaseous disorders and their role in the development of hepatopulmonary syndrome in liver cirrhosis associated with COPD].

Nevzorova VA, Pestrikova TL, Kochetkova EA, Mokshina MV, Osvald M, Dutrele S, Massard Zh.

Eksp Klin Gastroenterol. 2013;(6):11-4. Russian.

PMID:
24772853
10.

Extracorporeal membrane oxygenation as a bridge to liver transplantation for acute respiratory distress syndrome-induced life-threatening hypoxaemia aggravated by hepatopulmonary syndrome.

Monsel A, Mal H, Brisson H, Luo R, Eyraud D, Vézinet C, Do CH, Lu Q, Vaillant JC, Hannoun L, Houssel P, Durand F, Rouby JJ.

Crit Care. 2011;15(5):R234. doi: 10.1186/cc10476. Epub 2011 Sep 29.

11.

Hepatopulmonary syndrome and liver sarcoidosis: a tale of two diseases.

Patel AN, Patel K, Mador MJ.

South Med J. 2009 Aug;102(8):844-7. doi: 10.1097/SMJ.0b013e3181ad624e.

PMID:
19593289
12.

[Hepatopulmonary syndrome in liver cirrhosis].

Culafić Dj, Perisić M, Rebić P.

Srp Arh Celok Lek. 2000 Jul-Aug;128(7-8):271-5. Serbian.

PMID:
11089435
13.

Gas exchange abnormalities in patients listed for liver transplantation.

Przybyłowski T, Krenke R, Fangrat A, Nasilowski J, Grabczak EM, Styczynski G, Pruszczyk P, Krawczyk M, Chazan R.

J Physiol Pharmacol. 2006 Sep;57 Suppl 4:313-23.

PMID:
17072060
14.

Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis.

Kerbert AJ, Verbeke L, Chiang FW, Laleman W, van der Reijden JJ, van Duijn W, Nevens F, Wolterbeek R, van Hoek B, Verspaget HW, Coenraad MJ.

PLoS One. 2015 Sep 17;10(9):e0138264. doi: 10.1371/journal.pone.0138264. eCollection 2015.

15.

Algorithm for prioritization of patients on the waiting list for liver transplantation.

Gambato M, Senzolo M, Canova D, Germani G, Tomat S, Masier A, Russo FP, Perissinotto E, Zanus G, Cillo U, Burra P.

Transplant Proc. 2007 Jul-Aug;39(6):1855-6.

PMID:
17692632
16.

Hepatopulmonary syndrome: the anaesthetic considerations.

Fauconnet P, Klopfenstein CE, Schiffer E.

Eur J Anaesthesiol. 2013 Dec;30(12):721-30. doi: 10.1097/EJA.0b013e328365bb6f. Review.

PMID:
24161936
17.

Occurrence of hepatopulmonary syndrome in patients with cirrhosis who are candidates for liver transplantation.

Macêdo LG, Lopes EP, Albuquerque Mde F, Markman-Filho B, Véras FH, Araújo AC, Ferraz AA.

J Bras Pneumol. 2010 Jul-Aug;36(4):432-40. English, Portuguese.

18.

Hepatopulmonary syndrome: favorable outcomes in the MELD exception era.

Iyer VN, Swanson KL, Cartin-Ceba R, Dierkhising RA, Rosen CB, Heimbach JK, Wiesner RH, Krowka MJ.

Hepatology. 2013 Jun;57(6):2427-35. doi: 10.1002/hep.26070. Epub 2013 Feb 15.

PMID:
22996424
19.

[Hepatopulmonary syndrome in liver transplantation candidates].

Parolin MB, Coelho JC, Puccinelli V, Schulz GJ, de Souza AM, de Barros JA.

Arq Gastroenterol. 2002 Jan-Mar;39(1):11-6. Portuguese.

PMID:
12184159
20.

(99m)Technetium-macroaggregated albumin perfusion lung scan versus contrast enhanced echocardiography in the diagnosis of the hepatopulmonary syndrome in children with chronic liver disease.

El-Shabrawi MH, Omran S, Wageeh S, Isa M, Okasha S, Mohsen NA, Zekry O, E-Bartan G, El-Karaksy HM.

Eur J Gastroenterol Hepatol. 2010 Aug;22(8):1006-12. doi: 10.1097/MEG.0b013e328336562e.

PMID:
20101183

Supplemental Content

Support Center